Evidence mapPaperPMID 41023309Full record

Trial reportAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Effects of a virtual iSupport Program on carers and people with dementia.

Lily Xiao, Shahid Ullah, Ying Yu, Claudia Meyer, Michael Chapman, Langduo Chen, Kai Ping Tan, Sue McKechnie, Mel Ottaway, Andre Queiroz De Andrade and 5 more

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Effects of a virtual iSupport Program on carers and people with dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  2. Article
  3. Article
  4. Review
  5. Supporting Family Caregivers in an Aging Society: The Need for Comprehensive, Evidence-Based Interventions.International journal of environmental research and public health · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lily XiaoCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.ORCID 0000-0002-4631-2443
Shahid UllahCollege of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Ying YuCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Claudia MeyerCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Michael ChapmanCanberra Health Services, Garran ACT, Australia.
Langduo ChenCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Kai Ping TanCanberra Health Services, Garran ACT, Australia.
Sue McKechnieCommunity Services, Resthaven Incorporated, Adelaide, South Australia, Australia.
Mel OttawayCommunity Services, Resthaven Incorporated, Adelaide, South Australia, Australia.
Andre Queiroz De AndradeQuality Use of Medicines and Pharmacy Research Centre, University of South Australia, Adelaide, South Australia, Australia.
Julie RatcliffeCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Craig WhiteheadSouthern Adelaide Local Health Network, Flinders Dr, Adelaide, South Australia, Australia.
Kam TranCollege of Nursing and Health Sciences, Flinders University, Adelaide, South Australia, Australia.
Yao WangXiangya School of Nursing, Central South University, Changsha, Hunan, China.
Alison KitsonInternational Learning Collaborative, Adelaide, South Australia, Australia.

Funding

2020 NHMRC/The Dementia Centre for Research Collaboration (DCRC) World-Class Research Project Grantsthe Australian Government via 2020 Medical Research Future Fund application ID: 2008321
6 · The paper itself

Abstract

introductionWe conducted a virtual iSupport Program intervention for carers of people living with dementia (PLWD).

methodsWe applied a pragmatic randomized controlled trial to evaluate a multicomponent program delivered virtually in four organizations (July 2022 to December 2024). The primary outcome was quality of life (QoL) of carers and PLWD at 12 months post-baseline, and the secondary outcomes were carers' self-efficacy, social support, reactions to behavior, PLWD's behavior frequency, hospital admissions, and emergency department presentations.

resultsOne hundred forty-nine carers enrolled in the study. The intervention group reported increased mental-health-related QoL points of 12.0 (p < 0.001), self-efficacy points of 14.8 to 18.5 (p < 0.001), social support points of 0.25 (p < 0.028), reduced reactions to behavior points of -0.25 (p < 0.028), and a 60% lower hospital admission rate (p = 0.045) at 12 months compared with the usual care group. DISCUSSION: The virtual iSupport Program showed benefits for both carers and PLWD in a 12-month intervention.

trial registrationAustralia New Zealand Clinical Trials Registry: ACTRN12622000199718. HIGHLIGHTS: A total of 149 dementia carers participated in the virtual iSupport program intervention trial. The program included skills training, peer support, and access to care services. The program improved mental health-related quality of life for carers. The program improved self-efficacy, social support, and reduced distress for carers. The program reduced 60% hospital admission rate for people with dementia.

Indexed as

CaregiversDementiaQuality of LifeSocial SupportAgedAged, 80 and overFemaleHumansMaleMiddle AgedSelf Efficacybehavioral problemdementiafamily caregivershealth services for the agedhome care servicesonline social supportquality of lifeself‐efficacy

Identifiers

PMID41023309
PMCPMC12479211

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.